Delivery Order SPE2DX22D0129-SPE2D826F0BCP
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $103,151.88 by the Defense Logistics Agency's Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $23,237.52 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,379.98 on September 29, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, has an ultimate completion date of September 30, 2025. The contract represents a competitive award...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,406 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. The contract, awarded on September 12, 2025, is a competitive award with no set-aside designation and carries an ultimate completion date of September 15, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order execution...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,142.24 by the Defense Logistics Agency's Medical Supply Chain on November 8, 2025, with a completion deadline of November 10, 2025. This is a firm fixed-price, non-set-aside competitive award to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (SPE2DX) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,247.80 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is unset-aside and has an ultimate completion date of September 9, 2025. The contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $838,944.36 by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price, competitively awarded contract (no set-aside used) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $729,981.18 by the Defense Logistics Agency's Medical Supply Chain on November 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $23,388.75 by the Defense Logistics Agency's Medical Supply Chain on October 16, 2025. This firm fixed price delivery order, with an ultimate completion date of October 17, 2025, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $133,270.80 by the Defense Logistics Agency Medical Supply Chain on September 30, 2025, with an ultimate completion date of October 1, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0BCPDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $38,280.84 by the Defense Logistics Agency's Medical Supply Chain division. The competitively awarded, firm fixed-price contract was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, delivers a broad portfolio of medical products and supplies under this framework, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability to fulfill open competition procurement requirements for critical medical supply needs supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. No set-aside designation was applied to this award.